| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-18 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-18 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-14 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-12 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-12 |